Georghiou Georgios P, Berman Marius, Bobovnikov Viacheslav, Vidne Bernardo A, Saute Milton
Department of Cardiothoracic Surgery, Rabin Medical Center, Beilinson Campus, Petah Tiqva and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Interact Cardiovasc Thorac Surg. 2004 Sep;3(3):437-41. doi: 10.1016/j.icvts.2004.03.003.
The aim of this retrospective study was to evaluate the mid-term outcome (average follow-up 10 months, range 6-18 months) and value of transaxillary single-port thoracic sympathectomy using a thoracoscope with an operating channel for the treatment of hyperhidrosis. Between December 1992 and October 2002, 176 consecutive patients (94 men, 82 women, mean age 21 years) with hyperhidrosis underwent thoracoscopic sympathectomy via a 12-mm single-port approach. Data on postoperative morbidity and outcome were analyzed to validate the technique. Mean operative time per side was 9 min; there was no conversion to an open procedure. Ninety-five percent of the patients were discharged the next day. Thirty-day mortality was zero. Complications included unilateral transient Horner's syndrome (n=1), residual pneumothorax requiring chest drainage from the port entry (n=4), and segmental atelectasis of the lung (n=4) which was treated conservatively. Complete relief of symptoms was observed in all patients at the 6-month follow-up; 45% experienced compensatory hyperhidrosis. Single-port thoracoscopic sympathectomy produces excellent medical and cosmetic results in patients with hyperhidrosis, and is associated with a short hospital stay and a low risk of complications. Overall satisfaction is high. A few patients may experience compensatory symptoms.
这项回顾性研究的目的是评估经腋窝单孔胸腔镜交感神经切除术治疗多汗症的中期疗效(平均随访10个月,范围6 - 18个月)及其价值。1992年12月至2002年10月期间,176例连续性多汗症患者(94例男性,82例女性,平均年龄21岁)通过12毫米单孔入路接受了胸腔镜交感神经切除术。分析术后发病率和疗效数据以验证该技术。每侧平均手术时间为9分钟;无中转开胸手术情况。95%的患者于次日出院。30天死亡率为零。并发症包括单侧短暂性霍纳综合征(n = 1)、需经切口置管引流的残留气胸(n = 4)以及保守治疗的节段性肺不张(n = 4)。在6个月的随访中,所有患者症状均完全缓解;45%的患者出现代偿性多汗。单孔胸腔镜交感神经切除术在多汗症患者中产生了良好的医学和美容效果,且住院时间短、并发症风险低。总体满意度较高。少数患者可能会出现代偿性症状。